VYXEOS LIPOSOMAL
44MG/100MG INF PLV CSL 5
SÚKL code | 0238217 |
---|---|
Name of the product | VYXEOS LIPOSOMAL |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | VYXEOS LIPOSOMAL |
Supplement | 44MG/100MG INF PLV CSL 5 |
Strenght | 44MG/100MG |
Pharmaceutical form | Powder for concentrate for solution for infusion |
Package | 5 |
Route | Intravenous use |
Wrap type | Vial |
Legal status | na lékařský předpis |
Active substance |
CYTARABINE (CYTARABINUM) DAUNORUBICIN (DAUNORUBICINUM) |
ATC group | L01XY01 |
ATC group name | CYTARABIN A DAUNORUBICIN |
Marketing authorisation information
Registration Number | EU/1/18/1308/003 |
---|---|
Type of MA | Orphan medicinal products |
MA status | R - active MA/authorised medicinal product |
MA Holder | Jazz Pharmaceuticals Ireland Ltd, Dublin |
MA Holder country | IRSKO |